Table 3.

number of patients by subgroups of pulmonary hypertension

Subgroup	All patients (N=260)	%
Group 1	38
Congenital heart disease	34	13.1%
Human immunodeficiency virus-associated pulmonary arterial hypertension	3	1.2%
Idiopathic pulmonary arterial hypertension	1	0.3%
Group 2	151
Heart failure with reduced ejection fraction	116	44.6%
Rheumatic mitral valve disease	30	11.5%
Other valvular heart diseases	5	1.9%
Group 3	61
Chronic obstructive pulmonary disease	15	5.8%
Post-Tuberculosis bronchiectasis	46	17.7%
Group 4	3
Group 5	7
Sicklecell anemia	2	0.8%
Others	5	1.9%